Clinical Trial Update: The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes [Phase 2]

View source ↗

Summary

The study aims to evaluate the safety and efficacy of XJN010 nasal spray in patients with Parkinson's disease experiencing off episodes; the trial is in Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• XJN010 nasal spray

Snippet

Sponsor: Guangzhou Novaken Pharm Co., Ltd. | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING